IPOPLUS

254.75

+7.62 +3.08%

17 Jun 2026

NSE Listed · Pharmaceuticals

Marksans Pharma Limited (MARKSANS)

Volume: 1,57,232Avg Vol 1W: 1,89,403Avg Vol 1M: 2,72,63352W Range:155270.7
₹254.75 3.08%
Key Ratios
Updated 2h ago
Market Cap₹11,427 Cr
Current Price₹254.75
Previous Close₹247.13
High / Low (52w)₹270.7 / ₹155
Volume1,57,232
Avg Vol (1W)1,89,403
Avg Vol (1M)2,72,633
Stock P/E26.47
Book Value₹66.71
Dividend Yield0.36%
ROE13.82%
ROA10.88%
Revenue (TTM)
Revenue Growth20.46%
Profit Margin14.16%
Total Debt₹0 Cr
Shares Outstanding45 Cr
Face Value₹1
EPS (TTM)₹3.27
P/B3.05
Debt / Equity0.11
50 DMA₹211.76
200 DMA₹183.09
Day change+3.08%
Price Chart
254.75 52.09% · 1Y
25515787.8L
2025-10-01
2026-06-16

20-day avg volume: 2.7L shares

Pros
  • Company is almost debt-free.
  • Revenue grew 21% YoY.
  • Net profit is growing year over year.
Quarterly Results
MetricMar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023Sept 2023Jun 2023Mar 2023Dec 2022Sept 2022Jun 2022Mar 2022Dec 2021Sept 2021Jun 2021Mar 2021Dec 2020Sept 2020Jun 2020Mar 2020
Revenue₹856 Cr₹754 Cr₹720 Cr₹620 Cr₹708 Cr₹682 Cr₹642 Cr₹591 Cr₹560 Cr₹586 Cr₹531 Cr₹500 Cr₹486 Cr₹480 Cr₹453 Cr₹434 Cr₹418 Cr₹363 Cr₹361 Cr₹349 Cr₹330 Cr₹358 Cr₹356 Cr₹331 Cr₹335 Cr
EBITDA₹206 Cr₹157 Cr₹139 Cr₹83 Cr₹120 Cr₹146 Cr₹127 Cr₹123 Cr₹105 Cr₹116 Cr₹115 Cr₹98 Cr₹107 Cr₹82 Cr₹80 Cr₹78 Cr₹58 Cr₹61 Cr₹61 Cr₹76 Cr₹100 Cr₹79 Cr₹68 Cr₹63 Cr₹60 Cr
Net Profit₹148 Cr₹113 Cr₹98 Cr₹58 Cr₹91 Cr₹105 Cr₹97 Cr₹89 Cr₹78 Cr₹83 Cr₹84 Cr₹69 Cr₹82 Cr₹63 Cr₹61 Cr₹60 Cr₹28 Cr₹48 Cr₹45 Cr₹63 Cr₹80 Cr₹59 Cr₹51 Cr₹49 Cr₹43 Cr
EPS3.272.52.171.2922.312.131.961.731.841.841.521.971.561.521.460.691.21.111.511.931.421.211.21
Profit & Loss (Annual)
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Revenue₹2,693 Cr₹2,228 Cr₹1,911 Cr₹1,533 Cr₹1,383 Cr₹1,135 Cr
EBITDA₹516 Cr₹435 Cr₹347 Cr₹256 Cr₹310 Cr₹166 Cr
Net Profit₹381 Cr₹314 Cr₹266 Cr₹185 Cr₹236 Cr₹121 Cr
EPS8.46.926.414.515.762.95
Balance Sheet
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Total Assets₹3,240 Cr₹2,681 Cr₹2,190 Cr₹1,640 Cr₹1,229 Cr₹903 Cr
Total Liabilities₹750 Cr₹595 Cr₹425 Cr₹417 Cr₹323 Cr₹254 Cr
Equity₹2,489 Cr₹2,086 Cr₹1,765 Cr₹1,223 Cr₹905 Cr₹649 Cr
Total Debt₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Cash Flow
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Operating₹333 Cr₹353 Cr₹300 Cr₹172 Cr₹227 Cr₹258 Cr
Investing₹-49 Cr₹-141 Cr₹-259 Cr₹-84 Cr₹-45 Cr₹-60 Cr
Financing₹-65 Cr₹-69 Cr₹198 Cr₹80 Cr₹-15 Cr₹-114 Cr
Free Cash Flow₹333 Cr₹353 Cr₹300 Cr₹172 Cr₹227 Cr₹258 Cr
Shareholding
Promoter 43.87% Institutions 14.72% Public 41.4%

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search